The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 Peninsula Health, Melbourne, VIC
- 2 Monash University, Melbourne, VIC
Correspondence: cgreen@phcn.vic.gov.au
Competing interests:
No relevant disclosures.
- 1. Wijdicks EF, Klein CJ. Guillain-Barré Syndrome. Mayo Clin Proc 2017; 92: 467-479.
- 2. Esposito S, Longo MR. Guillain–Barré syndrome. Autoimmun Rev 2017; 16: 96-101.
- 3. McGrogan A, Madle GC, Seaman HE, et al. The epidemiology of Guillain–Barré syndrome worldwide: a systematic literature review. Neuroepidemiology 2009; 32: 150-163.
- 4. Sejvar JJ, Baughman AL, Wise M, et al. Population incidence of Guillain–Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011; 36: 123-133.
- 5. Netto AB, Taly AB, Kulkarni GB, et al. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J Neurosci Rural Pract 2017; 8: 68-73.
- 6. de Boisanger L. Outcomes for patients with Guillain–Barré syndrome requiring mechanical ventilation: a literature review. Ir J Med Sci 2016; 185: 11-15.
- 7. Wu X, Li C, Zhang B, et al. Predictors for mechanical ventilation and short-term prognosis in patients with Guillain–Barré syndrome. Crit Care 2015; 19: 310.
- 8. González-Suárez I, Sanz-Gallego I, Rodríguez de Rivera FJ, et al. Guillain–Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases. BMC Neurol 2013; 13: 95.
- 9. Paul BS, Bhatia R, Prasad K, et al. Clinical predictors of mechanical ventilation in Guillain–Barré syndrome. Neurol India 2012; 60: 150-153.
- 10. Toamad U, Kongkamol C, Setthawatcharawanich S, et al. Clinical presentations as predictors of prolonged mechanical ventilation in Guillain–Barré syndrome in an institution with limited medical resources. Singapore Med J 2015; 56: 558-561.
- 11. Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain–Barré syndrome. Ann Neurol 2010; 67: 781-787.
- 12. Sharshar T, Polito A, Porcher R, et al. Relevance of anxiety in clinical practice of Guillain–Barre syndrome: a cohort study. BMJ Open 2012; 2: e000893.
- 13. Kalita J, Ranjan A, Misra UK. Outcome of Guillain–Barre syndrome patients with respiratory paralysis. QJM 2016; 109: 319-323.
- 14. Orlikowski D, Sharshar T, Porcher R, et al. Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain–Barré syndrome. Intensive Care Med 2006; 32: 1962-1969.
- 15. Ropper AH, Kehne SM. Guillain–Barré syndrome: management of respiratory failure. Neurology 1985; 35: 1662-1665.
- 16. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain–Barré syndrome. Arch Neurol 2001; 58: 893-898.
- 17. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (viewed Dec 2017).
- 18. Fokkink WR, Walgaard C, Kuitwaard K, et al. Association of albumin levels with outcome in intravenous immunoglobulin-treated Guillain–Barré syndrome. JAMA Neurol 2017; 74: 189-196.
- 19. Sharshar T, Chevret S, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain–Barré syndrome. Crit Care Med 2003; 31: 278-283.
- 20. Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain–Barré syndrome: a prospective study. Lancet Neurol 2006; 5: 1021-1028.
- 21. Durand MC, Lofaso F, Lefaucheur JP, et al. Electrophysiology to predict mechanical ventilation in Guillain–Barré syndrome. Eur J Neurol 2003; 10: 39-44.
- 22. Cheng BC, Chang WN, Chang CS, et al. Predictive factors and long-term outcome of respiratory failure after Guillain–Barré syndrome. Am J Med Sci 2004; 327: 336-340.
- 23. Durand MC, Prigent H, Sivadon-Tardy V, et al. Significance of phrenic nerve electrophysiological abnormalities in Guillain–Barré syndrome. Neurology 2005; 65: 1646-1649.
- 24. Fourrier F, Robriquet L, Hurtevent JF, et al. A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain–Barré syndrome. Crit Care 2011; 15: R65.
- 25. Kaida K, Kusunoki S, Kanzaki M, et al. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain–Barré syndrome. Neurology 2004; 62: 821-824.
- 26. Kannan Kanikannan MA, Durga P, Venigalla NK, et al. Simple bedside predictors of mechanical ventilation in patients with Guillain–Barre syndrome. J Crit Care 2014; 29: 219-223.
- 27. Kobori S, Kubo T, Otani M, et al. Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain–Barré syndrome. J Epidemiol 2017; 27: 311-316.
- 28. Sundar U, Abraham E, Gharat A, et al. Neuromuscular respiratory failure in Guillain–Barre Syndrome: evaluation of clinical and electrodiagnostic predictors. J Assoc Physicians India 2005; 53: 764-768.
- 29. Verma R, Chaudhari TS, Raut TP, et al. Clinico-electrophysiological profile and predictors of functional outcome in Guillain–Barre syndrome (GBS). J Neurol Sci 2013; 335: 105-111.
- 30. Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Guillain–Barré syndrome in the northwest of Iran. Ann Saudi Med 2006; 26: 22-27.
- 31. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 1991; 14: 1103-1109.
- 32. Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-753.
- 33. Strauss J, Aboab J, Rottmann M, et al. Plasma cortisol levels in Guillain–Barré syndrome. Crit Care Med 2009; 37: 2436-2440.
- 34. Basiri K, Dashti M, Haeri E. Phrenic nerve CMAP amplitude, duration, and latency could predict respiratory failure in Guillain–Barre syndrome. Neurosciences (Riyadh) 2012; 17: 57-60.
- 35. Zifko U, Chen R, Remtulla H, et al. Respiratory electrophysiological studies in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 1996; 60: 191-194.
- 36. Gourie-Devi M, Ganapathy GR. Phrenic nerve conduction time in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 1985; 48: 245-249.
- 37. Kaida K, Morita D, Kanzaki M, et al. Anti-ganglioside complex antibodies associated with severe disability in GBS. J Neuroimmunol 2007; 182: 212-218.
- 38. Dourado ME, Duarte RC, Ferreira LC, et al. Anti-ganglioside antibodies and clinical outcome of patients with Guillain–Barré Syndrome in northeast Brazil. Acta Neurol Scand 2003; 108: 102-108.
- 39. Sipilä JO, Kauko T, Soilu-Hänninen M. Admission sodium level and prognosis in adult Guillain–Barré syndrome. Int J Neurosci 2017; 127: 344-349.
- 40. Yamagishi Y, Suzuki H, Sonoo M, et al. Markers for Guillain-Barre syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst 2017; 22: 433-439.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Abstract
Objective: To systematically review the literature regarding the ability of clinical features to predict respiratory failure in patients with Guillain–Barré syndrome (GBS).
Data sources: We searched the PubMed and Ovid MEDLINE databases with the search terms “guillain barre syndrome” OR “acute inflammatory demyelinating polyneuropathy” OR “acute motor axonal neuropathy” OR “acute motor sensory axonal neuropathy” AND “respiratory failure” OR “mechanical ventilation”. We excluded articles that did not report the results of original research (eg, review articles, letters), were case reports or series (ten or fewer patients), were not available in English, reported research in paediatric populations (16 years of age or younger), or were interventional studies. Article quality was assessed with the Newcastle–Ottawa quality assessment scale.
Data synthesis: Thirty-four relevant studies were identified. Short time from symptom onset to hospital admission (less than 7 days), bulbar (odds ratio [OR], 9.0; 95% CI, 3.94–20.6; P < 0.001) or neck weakness (OR, 6.36; 95% CI, 2.32–17.5; P < 0.001), and severe muscle weakness at hospital admission were associated with increased risk of intubation. Facial weakness (OR, 3.74; 95% CI, 2.05–6.81; P < 0.001) and autonomic instability (OR, 6.40; 95% CI, 2.83–14.5; P < 0.001) were significantly more frequent in patients requiring intubation in our meta-analyses; however, the differences were not statistically significant in individual multivariable analysis studies. Four predictive models have been developed to assess the risk of respiratory failure for patients with GBS, each with good to excellent discriminative power (area under the receiver operating characteristic curve, 0.79–0.96).
Conclusions and relevance: Early identification of GBS patients at risk of respiratory failure could reduce the rates of adverse outcomes associated with delayed intubation. Algorithms that predict a patient’s risk of subsequent respiratory failure at hospital admission appear more reliable than individual clinical variables.